Variant report
Variant | nsv933497 |
---|---|
Chromosome Location | chr2:50692381-50699386 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:50698680..50701343-chr2:50702519..50705361,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs569319151 | chr2:50692439-50692440 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs563591672 | chr2:50692455-50692456 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs12713101 | chr2:50692459-50692460 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs368634515 | chr2:50692460-50692461 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs535949911 | chr2:50692499-50692500 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs113964397 | chr2:50692534-50692535 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs371413077 | chr2:50692537-50692538 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs201134896 | chr2:50692552-50692553 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs202198828 | chr2:50692556-50692557 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs3213756 | chr2:50692560-50692561 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs200767650 | chr2:50692571-50692572 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs190177055 | chr2:50692576-50692577 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs181811622 | chr2:50692590-50692591 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs201871194 | chr2:50692600-50692601 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs200286439 | chr2:50692617-50692618 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs376483387 | chr2:50692633-50692634 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs201151714 | chr2:50692650-50692651 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs201963074 | chr2:50692663-50692664 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs563024628 | chr2:50692677-50692678 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs540872844 | chr2:50692688-50692689 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs116236999 | chr2:50692695-50692696 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs201553227 | chr2:50692706-50692707 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs377593434 | chr2:50692725-50692726 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs141468277 | chr2:50692742-50692743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs373454919 | chr2:50692744-50692745 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs549177612 | chr2:50692767-50692768 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs200579876 | chr2:50692809-50692810 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs10168838 | chr2:50692819-50692820 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs369272975 | chr2:50692857-50692858 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs371535183 | chr2:50692873-50692874 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs74925905 | chr2:50692888-50692889 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs548694406 | chr2:50692916-50692917 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs13398860 | chr2:50692940-50692941 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs572012282 | chr2:50692953-50692954 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs532853744 | chr2:50692999-50693000 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs548042504 | chr2:50693034-50693035 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs566106025 | chr2:50693036-50693037 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs536368194 | chr2:50693047-50693048 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs554318496 | chr2:50693062-50693063 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs377096516 | chr2:50693079-50693080 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs543353112 | chr2:50693081-50693082 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs569641076 | chr2:50693101-50693102 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs187219325 | chr2:50693115-50693116 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs759504 | chr2:50693162-50693163 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs759503 | chr2:50693165-50693166 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs5831125 | chr2:50693227-50693228 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs78711151 | chr2:50693230-50693231 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs540913843 | chr2:50693236-50693237 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs189289008 | chr2:50693240-50693241 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs552767129 | chr2:50693266-50693267 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Psychiatric disorder | 19734545 | CNVD |
Autism | 20844286 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Autism | 19218893 | CNVD |
Autism | 22209245 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Schizophrenia | 22118685 | CNVD |
Autism | 20663923 | CNVD |
Schizophrenia | 21285140 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21990379 | CNVD |
Schizophrenia | 22885689 | CNVD |
Autism | 20964600 | CNVD |
Schizophrenia | 19521646 | CNVD |
Attention deficit hyperactivity disorder | 22214315 | CNVD |
Chronic motor tic disorder | 22214315 | CNVD |
Schizophrenia | 22214315 | CNVD |
Mental retardation | 19896112 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:50691200-50711600 | Weak transcription | Fetal Brain Female | brain |
2 | chr2:50691200-50716000 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
3 | chr2:50691400-50703000 | Weak transcription | Brain Hippocampus Middle | brain |
4 | chr2:50691600-50718600 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
5 | chr2:50692000-50692400 | Weak transcription | Brain Germinal Matrix | brain |
6 | chr2:50692400-50692600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
7 | chr2:50692400-50695600 | Enhancers | Brain Germinal Matrix | brain |
8 | chr2:50692600-50705400 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
9 | chr2:50695200-50696200 | Enhancers | Stomach Mucosa | stomach |
10 | chr2:50695600-50709400 | Weak transcription | Brain Germinal Matrix | brain |
11 | chr2:50696600-50698000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr2:50697000-50697400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
13 | chr2:50697000-50697400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
14 | chr2:50699000-50742000 | Weak transcription | Cortex derived primary cultured neurospheres | brain |